Sign in
4

Changes in Ownership

FibroBiologics, Inc. Filed Acc 0001641172-25-014512

Options or other derivatives

  • Chief Financial Officer acquired 450,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Davis Jason Chief Financial Officer 2025-06-09 Grant or award · Stock Option (Right to Buy) +450,000 450,000 D: show line 1 in the form
Loading xslF345X05/ownership.xml…